IP Library › Granted Patent US 7,585,881
Granted Patent B2
US 7,585,881 · App. 11/053,752 · Granted Sep 8, 2009

Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,585,881
App. No.
11/053,752
Granted
Sep 8, 2009
Kind
B2
Abstract

The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.

Claims (2)

1. A compound or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical formulation comprising as active ingredient a therapeutically effective amount of the compound according to claim 1 in association with one or more pharmaceutically acceptable diluents, excipients and/or inert carriers.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2007
From: NPS PHARMACEUTICALS, INC.; ASTRAZENECA AB
To: ASTRAZENECA AB
Reel/Frame 020045/0150 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2007
From: EDWARDS, LOUISE; ISAAC, METHVIN; JOHANSSON, MARTIN; KERS, ANNIKA; MALMBERG, JOHAN; MCLEOD, DONALD; MINIDIS, ALEXANDER; STAAF, KARIN; SLASSI, ABDELMALIK; STEFANAC, TOMISLAV; STORMANN, THOMAS; WENSBO, DAVID; XIN, TOA; ARORA, JALAJ
To: ASTRAZENECA AB; NPS PHARMACEUTICALS, INC.
Reel/Frame 019707/0011 →